BUSINESS MODEL

Your search results

The Global drug delivery market is poised to be USD 150 billion with the oral segment in which Athena operates making the majority 40%.

HIGH QUALITY SUPPLIER

DRUG DELIVERY MARKET IN 2014

Athena is predominantly a Business to a Business pharma company and works on a client-centric model. We use our platform technologies to develop, scale up and commercialize products for our clients for various advanced and pharmerging markets. Our team of professionals is always aligned with the needs of the client and engages with them at multiple levels to deliver products which are customized to serve their needs for a particular market segment.
Our EU GMP level Factory at striking distance from Mumbai in India manufactures high-quality products in a GMP environment. Our state of the art R & D center is engaged in delivering to the clients’ innovative and value-added products that would enrich their product portfolio and also helps them plug gaps in their therapeutic width and depth. We undertake for our clients a complete gamut of activities and provide complete solutions for the partner’s product needs right from prototype development, industrial scale up to Commercial Supplies.

Fee for Development Model

Prototype development
Product optimization
Technical scale up
Exhibit batches
Dossier development

Dossier Licensing and Supply

Industrial scale up
Commercial supplies

Scientific Support

Proof of concept
Pilot and Pivotal studies
Clinical/BE studies

Compare Listings